相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An Efficient Metadynamics-Based Protocol To Model the Binding Affinity and the Transition State Ensemble of G-Protein-Coupled Receptor Ligands
Noureldin Saleh et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Structure of the full-length glucagon class B G-protein-coupled receptor
Haonan Zhang et al.
NATURE (2017)
Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators
Gaojie Song et al.
NATURE (2017)
Crystal structures of agonist-bound human cannabinoid receptor CB1
Tian Hua et al.
NATURE (2017)
Modulation of CBI cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities
Leepakshi Khurana et al.
NEUROPHARMACOLOGY (2017)
Investigating allosteric effects on the functional dynamics of β2-adrenergic ternary complexes with enhanced-sampling simulations
Noureldin Saleh et al.
CHEMICAL SCIENCE (2017)
Differences between G-Protein-Stabilized Agonist-GPCR Complexes and their Nanobody-Stabilized Equivalents
Noureldin Saleh et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor
Robert B. Laprairie et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Targeting the endocannabinoid system: future therapeutic strategies
Oier Aizpurua-Olaizola et al.
DRUG DISCOVERY TODAY (2017)
Identification of Two Distinct Sites for Antagonist and Biased Agonist Binding to the Human Chemokine Receptor CXCR3
Lampros Milanos et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
A Three-Site Mechanism for Agonist/Antagonist Selective Binding to Vasopressin Receptors
Noureldin Saleh et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists
Yi Zheng et al.
NATURE (2016)
High-resolution crystal structure of the human CB1 cannabinoid receptor
Zhenhua Shao et al.
NATURE (2016)
Extra-helical binding site of a glucagon receptor antagonist
Ali Jazayeri et al.
NATURE (2016)
Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile)
John A. Christopher et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects
Bogna M. Ignatowska-Jankowska et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor
Elham Khajehali et al.
MOLECULAR PHARMACOLOGY (2015)
Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain
Andrew S. Dore et al.
NATURE (2014)
Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator
Huixian Wu et al.
SCIENCE (2014)
Modulating the endocannabinoid system in human health and disease successes and failures
Pal Pacher et al.
FEBS JOURNAL (2013)
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Andrew C. Kruse et al.
NATURE (2013)
Emerging paradigms in GPCR allostery: implications for drug discovery
Denise Wootten et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex
Qiuxiang Tan et al.
SCIENCE (2013)
Biomolecular Simulation: A Computational Microscope for Molecular Biology
Ron O. Dror et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 41 (2012)
Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists
David R. Janero
EXPERT OPINION ON EMERGING DRUGS (2012)
The allosteric vestibule of a seven transmembrane helical receptor controls G-protein coupling
Andreas Bock et al.
NATURE COMMUNICATIONS (2012)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Latest advances in cannabinoid receptor agonists
Ganesh A. Thakur et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
Actions of delta-9-tetrahydrocannabinol in cannabis: Relation to use, abuse, dependence
Ziva D. Cooper et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2009)
Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond
Roger G. Pertwee
ADDICTION BIOLOGY (2008)
CB1 receptor antagonism: biological basis for metabolic effects
Vincenzo Di Marzo
DRUG DISCOVERY TODAY (2008)
Targeting the endocannabinoid system: to enhance or reduce?
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2008)
Pharmacotherapeutic targeting of the endocannabinoid signaling system: Drugs for obesity and the metabolic syndrome
V. Kiran Vemuri et al.
PHYSIOLOGY & BEHAVIOR (2008)
Allosterism and cannabinoid CB1 receptors:: the shape of things to come
Ruth A. Ross
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Allosteric modulation of the cannabinoid CB1 receptor
MR Price et al.
MOLECULAR PHARMACOLOGY (2005)
Self-administration of Δ9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys
Z Justinova et al.
PSYCHOPHARMACOLOGY (2003)
分享论文
